Oral bisphosphonates causing adverse effects in therapeutic use

Known as: Oral bisphosphonates 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2017
012320062017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Oral bisphosphonates (BP) have been prescribed widely in osteoporosis patients. Bisphosphonate-related osteonecrosis… (More)
Is this relevant?
2016
2016
OBJECTIVE To evaluate the mandibular cortical indices in osteoporotic women receiving oral bisphosphonates (oBPs). MATERIAL AND… (More)
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
2016
2016
INTRODUCTION Patients with breast cancer under aromatase inhibitor (AI) treatment often develop osteoporosis and their average… (More)
Is this relevant?
Review
2016
Review
2016
Oral bisphosphonates (BF) are drugs widely used in the treatment of osteoporosis and placed as first-line treatment for… (More)
Is this relevant?
2015
2015
The aim of this 12-month, observational study was to compare the effects of switching daily teriparatide (TPTD) to oral… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2015
Review
2015
OBJECTIVES Low adherence to treatment with bisphosphonates significantly impedes its effectiveness. The objectives were: (1) to… (More)
Is this relevant?
2015
2015
PURPOSE Bisphosphonate use has been associated with increased risk of fatal stroke. We examined the association between… (More)
  • table 2
Is this relevant?
2009
2009
BACKGROUND AND AIM Oral bisphosphonates have been shown to reduce the risk of fractures in patients with osteoporosis. It can be… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?